Allied Biotech Corporation
1780
Rank in Stocks
#20769
Allied Biotech Corporation operates as a global producer and supplier... Allied Biotech Corporation operates as a global producer and supplier specializing in carotenoids. The company's diverse product portfolio features key carotenoids such as: Beta-Carotene, known for imparting vibrant yellow to reddish-orange hues across numerous applications. Beta-Apo-8'-Carotenal, a versatile food colorant delivering shades from rich orange to deep red. Lycopene, a valuable nutrient that provides striking red tones for incorporation into food, dietary supplements, and pharmaceutical formulations. Canthaxanthin, which contributes reddish-orange colors specifically to food and beverage products. Lutein, another carotenoid frequently derived from or associated with green leafy vegetables (like spinach, kale, and broccoli) and egg yolks. Additionally, Allied Biotech offers Nano Coenzyme Q10, an antioxidant crucial for cellular energy production. The corporation caters to a diverse clientele across the food, beverage, dietary supplement, and animal feed sectors. Established in 2001, Allied Biotech Corporation maintains its headquarters in Taipei, Taiwan.
Share Price
$0.72248167
Last synced: 2026-11-10
Market Cap
$78.80M
Change (1 day)
-0.42%
Change (1 year)
20.39%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Allied Biotech Corporation (1780)
Category
Healthcare
Operating Margin for Allied Biotech Corporation (1780)
Operating Margin as of November 2026 TTM: 14.96%
According to Allied Biotech Corporation's latest financial reports, its current operating margin (TTM) is 14.96%. At the end of 2025 the company had an operating margin of 14.17%.
Operating Margin history for Allied Biotech Corporation from 2007 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 14.96% | 5.58% |
| 2025 | 14.17% | 29.76% |
| 2024 | 10.92% | -11.29% |
| 2023 | 12.31% | -13.31% |
| 2022 | 14.20% | 233.33% |
| 2021 | 4.26% | -74.32% |
| 2020 | 16.59% | -22.30% |
| 2019 | 21.35% | 12.37% |
| 2018 | 19.00% | 44.16% |
| 2017 | 13.18% | 18.74% |
| 2016 | 11.10% | 13.38% |
| 2015 | 9.79% | 250.90% |
| 2014 | 2.79% | 675.00% |
| 2013 | 0.36% | -96.70% |
| 2012 | 10.92% | 148.18% |
| 2011 | 4.40% | -40.22% |
| 2010 | 7.36% | 9.36% |
| 2009 | 6.73% | 5.82% |
| 2008 | 6.36% | -224.71% |
| 2007 | -5.10% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -98.70% |
DE
|
|
| 19.68% | -98.68% |
DE
|
|
| 13.26% | -99.11% |
JP
|
|
| 17.08% | -98.86% |
CH
|
|
| 14.92% | -99.00% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Allied Biotech Corporation's operating margin
What is Allied Biotech Corporation's operating margin?
Allied Biotech Corporation's operating margin is 14.96%, as of Nov 2026.
What was Allied Biotech Corporation's operating margin in 2025?
In 2025, Allied Biotech Corporation's operating margin was 14.17%, compared with 10.92% in 2024.
How has Allied Biotech Corporation's operating margin changed since 2020?
From 2020 to 2025, Allied Biotech Corporation's operating margin was highest in 2020 (16.59%) and lowest in 2021 (4.26%).
How does Allied Biotech Corporation's operating margin compare with similar companies?
Allied Biotech Corporation's operating margin (14.96%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.